Microbot Medical Inc.

NASDAQ: MBOT · Real-Time Price · USD
2.41
-0.06 (-2.43%)
At close: May 01, 2025, 3:59 PM
2.43
0.83%
After-hours: May 01, 2025, 06:14 PM EDT
-2.43%
Bid 1.8
Market Cap 83.73M
Revenue (ttm) n/a
Net Income (ttm) -11.44M
EPS (ttm) -0.73
PE Ratio (ttm) -3.3
Forward PE n/a
Analyst Buy
Ask 3.12
Volume 681,534
Avg. Volume (20D) 3,009,590
Open 2.49
Previous Close 2.47
Day's Range 2.41 - 2.54
52-Week Range 0.82 - 3.38
Beta 1.40

About MBOT

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional ...

Sector Healthcare
IPO Date Mar 25, 1992
Employees 20
Stock Exchange NASDAQ
Ticker Symbol MBOT
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for MBOT stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 273.44% from the latest price.

Stock Forecasts
3 weeks ago
+18.71%
Microbot Medical shares are trading higher after t... Unlock content with Pro Subscription
2 months ago
-9.41%
Microbot Medical shares are trading lower after the company announced a $13 million registered direct offering.